These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 38997543)

  • 1. Anti-α-1,4-D-polygalacturonic acid antibodies as a new biomarker for juvenile idiopathic arthritis.
    Huang J; Wu Z; Quan W; Ye X; Dai X; Luo J; Han X; Li X; Zheng W
    Clin Rheumatol; 2024 Sep; 43(9):2919-2926. PubMed ID: 38997543
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association between anti-α-1,4-D-polygalacturonic acid antibodies and Henoch-Schönlein purpura in children.
    Miao M; Li X; Wang Q; Zhu Y; Cui Y; Shao X
    J Int Med Res; 2019 Jun; 47(6):2545-2554. PubMed ID: 31068035
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-type II collagen antibodies, anti-CCP, IgA RF and IgM RF are associated with joint damage, assessed eight years after onset of juvenile idiopathic arthritis (JIA).
    Berntson L; Nordal E; Fasth A; Aalto K; Herlin T; Nielsen S; Rygg M; Zak M; Rönnelid J;
    Pediatr Rheumatol Online J; 2014; 12():22. PubMed ID: 24944545
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Measurement and evaluation of isotypes of anti-citrullinated fibrinogen and anti-citrullinated alpha-enolase antibodies in juvenile idiopathic arthritis.
    Moore TL; Gillian BE; Crespo-Pagnussat S; Feller L; Chauhan AK
    Clin Exp Rheumatol; 2014; 32(5):740-6. PubMed ID: 25068682
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnostic performance of anti-citrullinated protein/peptide antibodies in juvenile idiopathic arthritis.
    Pang SY; Liu HY; Huang YJ; Liu YF; Dai YM; Zeng P; Zeng HS
    Genet Mol Res; 2016 May; 15(2):. PubMed ID: 27323035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Autoantibodies and Gastrointestinal Symptoms in Colombian Children with Juvenile Idiopathic Arthritis.
    Gonzalez T; Malagon C; Guarnizo P; Mosquera AC; Chila-Moreno L; Romero-Sanchez C
    Curr Rheumatol Rev; 2018; 14(2):163-171. PubMed ID: 29308742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-type II collagen antibodies detection and avidity in patients with oligoarticular and polyarticular forms of juvenile idiopathic arthritis.
    Araujo GR; Fonseca JE; Fujimura PT; Cunha-Junior JP; Silva CH; Mourão AF; Canhão H; Goulart LR; Gonçalves J; Ueira-Vieira C
    Immunol Lett; 2015 May; 165(1):20-5. PubMed ID: 25800643
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel reactive epitope-based antigen targeted by serum autoantibodies in oligoarticular and polyarticular juvenile idiopathic arthritis and development of an electrochemical biosensor.
    Araujo GR; Fujimura PT; Vaz ER; Silva TA; Rodovalho VR; Britto-Madurro AG; Madurro JM; Fonseca JE; Silva CH; Santos PS; Mourão AF; Canhão H; Goulart LR; Gonçalves J; Ueira-Vieira C
    Immunobiology; 2016 May; 221(5):634-40. PubMed ID: 26806845
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-MCV and anti-CCP antibodies-diagnostic and prognostic value in children with juvenile idiopathic arthritis (JIA).
    Lipinska J; Lipinska S; Kasielski M; Smolewska E
    Clin Rheumatol; 2016 Nov; 35(11):2699-2706. PubMed ID: 27457366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of screening for coeliac disease in children with juvenile idiopathic arthritis.
    Öman A; Hansson T; Carlsson M; Berntson L
    Acta Paediatr; 2019 Apr; 108(4):688-693. PubMed ID: 30265401
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibodies to Cyclic Citrullinated Peptides in Patients With Juvenile Idiopathic Arthritis and Patients With Rheumatoid Arthritis: Shared Expression of the Inherently Autoreactive 9G4 Idiotype.
    Peckham H; Cambridge G; Bourke L; Sen D; Radziszewska A; Leandro M; Ioannou Y
    Arthritis Rheumatol; 2017 Jul; 69(7):1387-1395. PubMed ID: 28380667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serological screening for coeliac disease in patients with juvenile idiopathic arthritis.
    Sahin Y; Sahin S; Barut K; Cokugras FC; Erkan T; Adrovic A; Kutlu T; Kasapcopur O
    Arab J Gastroenterol; 2019 Jun; 20(2):95-98. PubMed ID: 31182344
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of biomarkers in juvenile idiopathic arthritis patients and their significant association with disease severity: a comparative study.
    Gilliam BE; Chauhan AK; Low JM; Moore TL
    Clin Exp Rheumatol; 2008; 26(3):492-7. PubMed ID: 18578976
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of autoantibodies in patients with juvenile idiopathic arthritis: results from the German inception cohort ICON-JIA.
    Schulz C; Fuehner S; Schlüter B; Fobker M; Sengler C; Klotsche J; Niewerth M; Minden K; Foell D
    Pediatr Rheumatol Online J; 2022 Feb; 20(1):8. PubMed ID: 35109858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of anti-cyclic citrullinated peptide antibodies may be beneficial in RF-negative juvenile idiopathic arthritis patients.
    Spârchez M; Miu N; Bolba C; Iancu M; Spârchez Z; Rednic S
    Clin Rheumatol; 2016 Mar; 35(3):601-7. PubMed ID: 25994613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The diagnostic value of anti-cyclic citrullinated peptide (CCP) antibodies in children with Juvenile Idiopathic Arthritis.
    Brunner J; Sitzmann FC
    Clin Exp Rheumatol; 2006; 24(4):449-51. PubMed ID: 16956438
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum and salivary inflammatory biomarkers in juvenile idiopathic arthritis-an explorative cross-sectional study.
    Cetrelli L; Lundestad A; Gil EG; Fischer J; Halbig J; Frid P; Angenete O; Rosén A; Tylleskär KB; Luukko K; Nordal E; Åstrøm AN; Skeie MS; Stunes AK; Bletsa A; Sen A; Feuerherm AJ; Rygg M
    Pediatr Rheumatol Online J; 2024 Mar; 22(1):36. PubMed ID: 38461338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of serum levels of TNF-α in a longitudinal follow-up study in 98 patients with juvenile idiopathic arthritis treated with anti-TNF-α biological drugs.
    Morozova N; Avramovič MZ; Markelj G; Toplak N; Avčin T
    Clin Rheumatol; 2024 Jul; 43(7):2287-2293. PubMed ID: 38775868
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anticyclic citrullinated peptide antibodies in juvenile idiopathic arthritis.
    Brunner JK; Sitzmann FC
    Mod Rheumatol; 2006; 16(6):372-5. PubMed ID: 17164999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population.
    Kwok JS; Hui KH; Lee TL; Wong W; Lau YL; Wong RW; Kim DL; Jones BM
    Scand J Rheumatol; 2005; 34(5):359-66. PubMed ID: 16234183
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.